Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.04 -0.03 (-1.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Selling, General & Administrative (2020 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) posted Selling, General & Administrative of $4.75 million for Q2 2026, up 2.6% from $4.63 million a year earlier and up 1.8% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Acumen Pharmaceuticals was $18.63 million, down 5.8% year-over-year; for FY2025, it came in at $18.95 million, down 6.3% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 69.6% (FY2020 to FY2025).
  • In prior years, Acumen Pharmaceuticals' Selling, General & Administrative was $20.22 million in FY2024 (+7.4%), $18.82 million in FY2023 (+46.2%), $12.88 million in FY2022 (+76.9%) and $7.28 million in FY2021 (+438.8%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative since Q1 2025.
  • On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 3.9%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 844.7%; the weakest was Q3 2025, with a decline of 9.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $4.67 million (Q1 2026), $4.67 million (Q4 2025) and $4.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Acumen Pharmaceuticals 147.52 Mn 147.52 Mn - 4.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.75 Mn
Mar 31, 2026 4.67 Mn
Dec 31, 2025 4.67 Mn
Sep 30, 2025 4.55 Mn
Jun 30, 2025 4.63 Mn
Mar 31, 2025 5.10 Mn
Dec 31, 2024 5.03 Mn
Sep 30, 2024 5.02 Mn
Jun 30, 2024 4.85 Mn
Mar 31, 2024 5.33 Mn
Dec 31, 2023 5.19 Mn
Sep 30, 2023 4.86 Mn
Jun 30, 2023 4.35 Mn
Mar 31, 2023 4.42 Mn
Dec 31, 2022 3.50 Mn
Sep 30, 2022 3.06 Mn
Jun 30, 2022 3.09 Mn
Mar 31, 2022 3.22 Mn
Dec 31, 2021 2.74 Mn
Sep 30, 2021 2.14 Mn
API Access

Acumen Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABOS&period=max&api_key=YOUR_API_KEY